QIU Weiwen, LAN Haiyuan, WANG Huaqiang. Correlating White Matter Hyperintensities Severity with Collateral Disease Syndrome Type Distribution. 2024. biomedRxiv.202411.00015
Correlating White Matter Hyperintensities Severity with Collateral Disease Syndrome Type Distribution
Corresponding author: QIU Weiwen, weiwenq@hotmail.com
DOI: 10.12201/bmr.202411.00015
-
Abstract: 【Abstract】 Objective To explore the relationship between the severity of white matter hyperintensities (WMH) and the distribution of collateral disease syndrome types. Methods A cross-sectional study was conducted, including 208 patients with cerebral small vessel disease and white matter hyperintensities who met the criteria. All enrolled subjects in the study completed the collateral disease syndrome differentiation. WMH was graded on magnetic resonance imaging fluid-attenuated inversion recovery (FLAIR) sequences using the Fazekas scale and measured for volume. Results Among the 208 patients, there were 52 cases (25.00%) of the Brain Collateral Impoverishment (BCI) type, with a Fazekas score of 3 (2, 3), and WMH volume of (8.80±9.37) ml; 67 cases (32.21%) of the Brain Collateral Stasis (BCS) type, with a Fazekas score of 4 (3, 4), and WMH volume of (13.42±9.18) ml; 47 cases (22.60%) of the Brain Collateral Constraint (BCC) type, with a Fazekas score of 4 (3, 5), and WMH volume of (14.60±10.07) ml; and 42 cases (20.19%) of the Brain Collateral Occlusion (BCO) type, with a Fazekas score of 4 (4, 5), and WMH volume of (18.65±10.71) ml. Of these, 55 patients (26.44%) with a Fazekas score of 1-2 were most commonly of the BCI type, 105 patients (50.48%) with a score of 3-4 were most commonly of the BCS type, and 48 patients (23.08%) with a score of 5-6 were most commonly of the BCO type. There were statistically significant differences in Fazekas scores and WMH volumes between the BCI and BCO types and other syndrome types (P<0.05), but no significant differences were observed between the BCS and BCC types (P>0.05).Conclusion The severity of WMH corresponds to a certain distribution of collateral disease syndrome types, and can serve as a reference indicator for assessing the severity of illness in patients with collateral disease.
Key words: collateral disease; syndrome differentiation; white matter hyperintensities; cerebral small vessel disease.Submit time: 8 November 2024
Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity. -
图表
-
Construction of specific medical records assessment system for CAP patients disease severity based on PDCA. 2024. doi: 10.12201/bmr.202409.00064
ZHOU Hai, PENG Feiling, WEI Changfa. Research and Practice on the Construction of Syndrome Differentiation Knowledge Graph of Diagnostics of Traditional Chinese Medicine. 2020. doi: 10.12201/bmr.202004.00036
liruiyao, xujingyi, daihaoyu, sunhuiwen, wutianxing. Deep confidence network-based prediction of microvascular complications in type 2 diabetes mellitus. 2024. doi: 10.12201/bmr.202404.00021
lixintai, tonli, yangjw. Contrast agent induced "cerebral infarction" imaging changes: a case of Contrast-induced Encephalopathy and literature review. 2024. doi: 10.12201/bmr.202406.00035
Liu Xiaoying, Xu Kefei. A case of treating lupus nephritis in a child with Belizumab combined with traditional Chinese medicine syndrome differentiation formula. 2024. doi: 10.12201/bmr.202409.00041
Lianwanmin. Construction practice of cerebrovascular disease database based on Data Governance. 2022. doi: 10.12201/bmr.202210.00011
HU Linlin, ZHANG Yonghua. Study on early intervention of insomnia in depression treated by TCM syndrome differentiation. 2024. doi: 10.12201/bmr.202408.00051
sunjie. Design and Application of the Single-disease Management System. 2023. doi: 10.12201/bmr.202303.00020
Duan Lei, Zhang Xiang, Zhang Yan. Study on the Measurement and Application of Diagnostic and Treatment Difficulty in Disease Categories. 2024. doi: 10.12201/bmr.202403.00007
LIU Mi-mi, DU Guo-xia, ZHOU Yi, WU Bin, WU Xiao-ying. Construction and preliminary application of liver cirrhosis special disease database. 2021. doi: 10.12201/bmr.202104.00014
-
ID Submit time Number Download 1 2024-10-07 bmr.202411.00015V1
Download -
-
Public Anonymous To author only
Get Citation
Article Metrics
- Read: 48
- Download: 0
- Comment: 0